PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice

作者: Sean H. Adams , Chunli Lei , Carolyn M. Jodka , Svetlana E. Nikoulina , Julie A. Hoyt

DOI: 10.1093/JN/136.1.195

关键词: ObesityWeight lossRespiratory quotientEndocrinologyBiologyPeptide YYInternal medicineDiminutionLipolysisFat padDiet-induced obese

摘要: In rodents, weight reduction after peptide YY[3-36] (PYY[3-36]) administration may be due largely to decreased food consumption. Effects on other processes affecting energy balance (energy expenditure, fuel partitioning, gut nutrient uptake) remain poorly understood. We examined whether s.c. infusion of 1 mg/(kg x d) PYY[3-36] (for up 7 increased metabolic rate, fat combustion, and/or fecal loss in obese mice fed a high-fat diet. transiently reduced intake (e.g., 25-43% lower at d 2 relative pretreatment baseline) and body 9-10% vs. 3 separate studies. Mass-specific rate kJ/(kg h) PYY[3-36]-treated did not differ from controls. The dark cycle respiratory quotient (RQ) was decreased. On 2, it 0.747 +/- 0.008 compared with 0.786 0.004 for controls (P < 0.001); light RQ throughout the study (0.730 0.006) (0.750 0.009; P 0.001). Epididymal pad approximately 50% than 0.01). Fat lipolysis ex vivo stimulated by PYY[3-36]. basal gallbladder emptying nonobese mice. Fecal negligible ( 2% ingested energy) between Thus, negative diet-induced results maintenance mass-specific expenditure. highlight potential drive mobilization stores help meet requirements this model.

参考文章(33)
T.N. Pappas, H.T. Debas, A.M. Chang, I.L. Taylor, Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs Gastroenterology. ,vol. 91, pp. 1386- 1389 ,(1986) , 10.1016/0016-5085(86)90191-5
Asish K. Saha, Neil B. Ruderman, Malonyl-CoA and AMP-activated protein kinase: An expanding partnership Molecular and Cellular Biochemistry. ,vol. 253, pp. 65- 70 ,(2003) , 10.1023/A:1026053302036
M. A. Heffernan, W. J. Jiang, A. W. Thorburn, F. M. Ng, Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism. American Journal of Physiology-endocrinology and Metabolism. ,vol. 279, ,(2000) , 10.1152/AJPENDO.2000.279.3.E501
Prasanth K. Chelikani, Alvin C. Haver, Roger D. Reidelberger, Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology. ,vol. 146, pp. 879- 888 ,(2005) , 10.1210/EN.2004-1138
Sean H. Adams, Wesley B. Won, Susan E. Schonhoff, Andrew B. Leiter, James R. Paterniti, Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels. Endocrinology. ,vol. 145, pp. 4967- 4975 ,(2004) , 10.1210/EN.2004-0518
Ilia G. Halatchev, Kate L. J. Ellacott, Wei Fan, Roger D. Cone, Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology. ,vol. 145, pp. 2585- 2590 ,(2004) , 10.1210/EN.2003-1754
N M Martin, C J Small, A Sajedi, M Patterson, M A Ghatei, S R Bloom, Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin. International Journal of Obesity. ,vol. 28, pp. 886- 893 ,(2004) , 10.1038/SJ.IJO.0802646
Melanie Henry, Lorraine Ghibaudi, Jun Gao, Joyce J. Hwa, Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obesity Research. ,vol. 13, pp. 36- 47 ,(2005) , 10.1038/OBY.2005.6
Mercedes Alvarez Bartolomé, María Borque, Javier Martinez-Sarmiento, Eugenio Aparicio, Carmen Hernández, Lucio Cabrerizo, J.A. Fernández-Represa, Peptide YY Secretion in Morbidly Obese Patients Before and After Vertical Banded Gastroplasty Obesity Surgery. ,vol. 12, pp. 324- 327 ,(2002) , 10.1381/096089202321088084